Cannabis Science, Inc. announced the launch of the Company’s new corporate advisory structure and appoints new leadership for its Scientific Advisory and International Government Affairs Advisory Boards. Dr. Julius Garvey, a renowned vascular surgeon, has been named President of CBIS’ Scientific Advisory Board, and Mr. Jacques Walker, an experienced entrepreneur, has been named President of the Company’s International Government Affairs Advisory Board. Members of the two Corporate Advisory Boards will be announced shortly. Dr. Garvey will lead the Scientific Advisory Board’s efforts to provide CBIS with guidance on the Company’s research and development activities, clinical trials, and technical collaborations in the markets where CBIS operates. Mr. Walker and members of the International Government Affairs Board will primarily focus on advising CBIS on its initiatives and collaborations with government entities, the general public and private-sector stakeholders worldwide. Dr. Garvey joined Cannabis Science’s Scientific Advisory Board in 2015, and worked closely with the Company’s former Chief Medical Officer, Dr. Allen Herman. Julius Garvey, M.D., F.A.C.S, F.R.C.S.(C), F.I.C.S., F.A.C.Ph., F.A.C.C.W.S. is a Board-Certified surgeon specializing in the diagnosis and treatment of vascular diseases. Mr. Jacques Walker joined Cannabis Science’s International Government Affairs Board in 2016. In that year, Mr. Walker helped organize and coordinate the Company’s visit to Namibia and South Africa, working closely with other Advisory Board Members, including Mr. Melvin Foote, President & CEO of CFA.